The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Mathematical Model for the Natural History of Human Papillomavirus Infection and Cervical Carcinogenesis
Abstract
The authors constructed a Markov model as part of a systematic review of cervical cytology conducted at the Duke University Evidence-based Practice Center (Durham, North Carolina) between October 1997 and September 1998. The model incorporated states for human papillomavirus infection (HPV), low- and high-grade squamous intraepithelial lesions, and cervical cancer stages I-IV to simulate the natural history of HPV infection in a cohort of women from ages 15 to 85 years. The age-specific incidence rate of HPV, and regression and progression rates of HPV and squamous intraepithelial lesions, were obtained from the literature. The effects of varying natural history parameters on cervical cancer incidence were evaluated by using sensitivity analysis. The base-case model resulted in a lifetime cervical cancer risk of 3.67% and a lifetime cervical cancer mortality risk of 1.26%, with a peak incidence of 81/100,000 at age 50 years. Age-specific distributions of precursors were similar to reported data. Lifetime risk of cancer was most sensitive to the incidence of HPV and the probability of rapid HPV progression to high-grade lesions (two- to threefold variations in risk). The model approximates the age-specific incidence of cervical cancer and provides a tool for evaluating the natural history of HPV infection and cervical cancer carcinogenesis as well as the effectiveness and cost-effectiveness of primary and secondary prevention strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Due to unavailability of any empirically derived estimates on the natural history of progression in undiagnosed cases of cancer as well as their probability of showing symptoms from India, parameter values derived from a mathematical model developed by Myers et al were used. [16]”
From Cost effectiveness of strategies for cervical cancer prevention in India (2020) · cites this paper as [16]
Citations
Cites
Markov Models in Medical Decision Making: A Practical Guide
Sonnenberg, F. A., & Beck, J. R. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300409 · Cited by 2,419
NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Loria, G. R., Ierman, R. O. B., Eardsley, L. E. B., & Hang, H. J. C. (1998) · Cited by 1,890
SCHIFFMAN, M. H., Bauer, H. M., Hoover, R. N., Glass, A. G., Cadell, D. M., Rush, B. B., Scott, D. R., Sherman, M. E., Kurman, R. J., Wacholder, S., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.12.958 · Cited by 1,197
Epidemiology of Genital Human Papillomavirus Infection
Koutsky, L. A. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00177-0 · Cited by 1,103
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J. A., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 940
Eddy, D. M. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-214 · Cited by 841
Meta-analysis of Pap Test Accuracy
Fahey, M. T., Irwig, L., & Macaskill, P. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117485 · Cited by 690
Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women
Hildesheim, A., SCHIFFMAN, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P., Sherman, M. E., et al. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.2.235 · Cited by 682
Quinn, M. A., Babb, P., Jones, J., & Allen, E. (1999) · BMJ · doi:10.1136/bmj.318.7188.904 · Cited by 571
Moscicki, A., Shiboski, S. C., Broering, J. M., Powell, K., Clayton, L., Jay, N., Darragh, T. M., Brescia, R. J., Kanowitz, S., Miller, S., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70445-7 · Cited by 562
Cited by
Sorted by citations
Items 401–467 of 467
U.S. Cancer Morbidity: Modeling Age-Patterns of Cancer Histotypes
Mantón, K. G., Akushevich, I. V., & Kravchenko, J. S. (2009) · Statistics in the health sciences · doi:10.1007/978-0-387-78193-8_7
Luostarinen, T. (2015) · Työväentutkimus Vuosikirja
Sroczynski, G. (2009) · Publikationen an der Universität Bielefeld (Universität Bielefeld)
Gradíssimo, A. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Genitorialità e Gender: quale adozione per il figlio?
Sina, M. (2007) · Medicina e Morale · doi:10.4081/mem.2007.325
Targeting the human papillomavirus for prevention of cervical cancer
Nauclér, P. (2007) · Lund University Publications (Lund University)
Sénéjoux, A. (2008) · Côlon & Rectum · doi:10.1007/s11725-008-0101-0
Kivuti, L. W. (2014) · University of Nairobi Research Archive (University of Nairobi)
Mastrolorenzo, A., Supuran, C. T., & Zuccati, G. (2007) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.17.2.173
Dai, M., & Li, N. (2009) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/972009-812
Traitement des condylomes anaux récidivants
Sénéjoux, A. (2008) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2008.04.015
STI screening and treatment in pregnancy
Richardson, K. K., & Shannon, M. (2012) · The Nurse Practitioner · doi:10.1097/01.npr.0000422203.95229.ee
Prevalência de infecção por HPV em jovens primíparas e fatores associados
Rama, C. H. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2009.tde-19112009-165049
Rama, C. H. (2006) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.6.2006.tde-06032007-102828
Schmidt, C., Shafey, O., Smith, R. A., Noller, L., Wheeler, C. M., Ades, T. B., Andrews, K. S., Goldie, S. J., Harper, D. M., Moscicki, A., et al. (2007)
Human papillomavirus infection and transmission among couples through heterosexual activity
Burchell, A. N. (2009) · eScholarship@McGill (McGill) · doi:10.82308/17001
Wainscott, M. (2013) · ThinkTech (Texas Tech University)
HPV infection in cervical cancer
Konno, R. (2012) · Toukeibu Gan · doi:10.5981/jjhnc.38.290
Sénéjoux, A. (2009) · Côlon & Rectum · doi:10.1007/s11725-009-0166-4
Current Indications and Future Directions
Gattoc, L., Nair, N., & Ault, K. A. (2013)
Public Health Impact of the HPV Vaccinations: A Research Update
Ragan, K. R. (2012) · The Corinthian
Management of a Chronically Ill Population: An Operations Approach to Liver Cancer Screening.
Lee, E. (2016) · Deep Blue (University of Michigan)
The HPV Vaccine Decision-Making Process: Inequality, Perceived Risk, and Trust
MacArthur, K. R. (2014) · OhioLink ETD Center (Ohio Library and Information Network)
A Survey on Cervical Cancer and its Vaccination in Chittagong City, Bangladesh
Islam, S. (2017) · Journal of Pharmacy & Pharmaceutics · doi:10.15436/2377-1313.17.024
MODELING DISEASE PROGRESSION AND RISK‐DIFFERENTIATED SCREENING FOR CERVICAL CANCER PREVENTION
Ley‐Chavez, A., & Higle, J. L. (2018) · Wiley eBooks · doi:10.1002/9781118960158.ch7
Genta, M. L. N. D. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-04112016-121046
Potential Predictors for HPV Vaccination Completion Rates
Sachdev, A., & Sekhon, K. (2018) · STEM Fellowship Journal · doi:10.17975/sfj-2018-004
Cost effectiveness analysis of cervical cancer screening in women until age 70
Quon, J. C. (2018) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20184111
Mathematical assessment of the role of pap screening on HPV transmission dynamics
Javame, A. (2015) · Mspace (University of Manitoba)
Şen, C. A., & Aksu, M. G. (2025) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub725
Research Progress of Human Papillomavirus Vaccine
胡, 彬. (2019) · Advances in Clinical Medicine · doi:10.12677/acm.2019.98154
Operations Research Models for Reducing Hospital Readmissions
Liu, X. (2019) · Deep Blue (University of Michigan)
Chatterjee, K., Mitra, A., Kar, S., Dutta, A., Ray, B., & Rahaman, S. R. (2019) · Asian Pacific Journal of Health Sciences · doi:10.21276/apjhs.2019.6.4.7
Estimation of The Transitional Probability Among Esophageal Cancer and Its Precancerous LesionsPreprint
Yu, Y., Xie, Y., Yang, X., Jing-Xuan, W. A. N. G., Chen, Z., Zhao, F., Ma, J., Wei, W., Qiao, Y., & Yang, C. (2020) · doi:10.21203/rs.3.rs-76203/v1
Gall, S. A. (2021) · CRC Press eBooks · doi:10.1201/9781003222590-72
Chen, Z., Yu, Y., Yang, X., Jing-Xuan, W. A. N. G., Wei, W., Qiao, Y., Chun-Xia, Y. A. N. G., & Li, D. A. I. (2021) · Research Square · doi:10.21203/rs.3.rs-917455/v1
DETERMINING PROBABILITY OF CANCER CELL TRANSFOMATION AT HUMAN PAPILLOMAVIRUS INFECTION
Buchatskyi, L. P. (2021) · Biotechnologia Acta · doi:10.15407/biotech14.05.074
Ethnicity and health in cervical cancer survivors : understanding vulnerability and resilience
Ortiz, J. A. (2010) · UNM’s Digital Repository (University of New Mexico)
Mantón, K. G., Akushevich, I. V., & Kravchenko, J. S. (2009) · Statistics in the health sciences · doi:10.1007/978-0-387-78193-8_9
Protecting Women from Cancer by Giving HPV-Vaccine
Padma, K. (2022) · Journal of Biomedical and Pharmaceutical Research · doi:10.32553/jbpr.v11i1.900
Oxidative Stress in the Pathogenesis of Cervical Cancer
Santosh, W., Freddy, A. J., & Winkins, D. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_277-1
Rohan, T. E., & Franco, E. L. (2002) · Springer eBooks · doi:10.1007/0-387-21605-7_26
Erin, R., Tekın, Y. B., Küçük, H., & Erel, Ö. (2022) · Journal of Experimental and Clinical Medicine · doi:10.52142/omujecm.39.4.28
Analysis of HR-HPV Prevalence among Unvaccinated Busan Women
Kim, D. H., & Lee, K. E. (2022) · Journal of Experimental & Biomedical Sciences/Biomedical Science Letters · doi:10.15616/bsl.2022.28.4.229
Bella, T., Babu Raj, S., Rajam, V., Joselet, L., Sherlin, V., & Christy, B. (2025) · International Journal of Pediatrics and Neonatology · doi:10.33545/26648350.2025.v7.i1a.121
Cadilla, A., Sande, L., & Alexander, K. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00155-2
Modeling the Impact of Active HPV Testing Intervention on Cervical Cancer Burden in IndiaPreprint
Arvinth, S., Tiwari, R., Tej, S. V., Sawarkar, P., Bhalla, P., Sivasubramanian, S., Rajwade, A., Ramakrishnan, G., & Bhatt, N. (2025) · medRxiv · doi:10.1101/2025.07.29.25332380
Moriña, D., Martí, J. I., Puig, P., & Díaz, M. (2020) · Figshare · doi:10.6084/m9.figshare.12922623
Xia, C., Xu, X., Zhao, X., Hu, S., Qiao, Y., Zhang, Y., Hutubessy, R. C. W., Basu, P. S., Broutet, N. J. N., Jit, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14150936
Xia, C., Xu, X., Zhao, X., Hu, S., Qiao, Y., Zhang, Y., Hutubessy, R. C. W., Basu, P. S., Broutet, N. J. N., Jit, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14150939
Zhao, X.-L., Zhao, S., Xia, C.-F., Hu, S.-Y., 段仙芝, Liu, Z.-H., Wang, Y.-Y., You, T.-T., Gao, M., Qiao, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22649258
Montealegre, J. R., Anderson, M. L., Hilsenbeck, S. G., Chiao, E. Y., Cantor, S. B., Parker, S. L., Daheri, M., Bulsara, S., Escobar, B., Deshmukh, A. A., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13126457
Cost-effectiveness of female-only and gender-neutral HPV vaccination strategies in Japan
Kim, M., & Shim, E. (2026) · Journal of Medical Economics · doi:10.1080/13696998.2025.2609508
Awareness, Perceptions, and Practices Regarding Human Papillomavirus Vaccination
M, K. K. K., & Vasanthi, M. (2023) · Journal of MedVerse Research & Practice · doi:10.65188/nurexus.1004
Kroon, K. R., Bogaards, J. A., & Berkhof, J. H. (2026) · International Journal of Cancer · doi:10.1002/ijc.70344
Yahia, M.-B. B. H. (2015) · theses.fr (ABES) · doi:10.70675/2ffa293cz0c26z4c51z8107zb7be97fc5070
Aldawsari, K., & Basir, F. A. (2026) · Networks and Heterogeneous Media · doi:10.3934/nhm.2026046
Wang, J., Wang, X., Xu, J., & Xu, Q. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1833764
Reifsnider, O. S. (2011) · TigerPrints (Clemson University)
Warts and All: HPV Vaccine Uptake.
Small, S. L. (2011) · Deep Blue (University of Michigan)
Metadata
- Authors
- Myers, E. R., McCrory, D. C., Nanda, K., Bastian, L., & Matchar, D. B.
- Affiliations
- Duke University (US)
- Corresponding author
- Myers, E. R.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-06-15
- Volume
- 151
- Issue
- 12
- Pages
- 1158-1171
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2113839478
- Cited by
- 470
- References
- 49
- Citations by year
- 2026: 4 · 2025: 16 · 2024: 8 · 2023: 14 · 2022: 13 · 2021: 17 · 2020: 18 · 2019: 11 · 2018: 19 · 2017: 20 · 2016: 12 · 2015: 22 · 2014: 24 · 2013: 32 · 2012: 19
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (290-97-0014)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Keywords
- HPV infection, cervical carcinogenesis, natural history of HPV infection, squamous intraepithelial lesions, cervical cancer incidence, cervical cancer mortality, lifetime cancer risk, Markov model, cervical cancer prevention, sensitivity analysis
- MeSH terms
- Adolescent, Adult, Aged, Antiviral Agents, Cell Transformation, Neoplastic, Uterine Cervical Neoplasms, Cost-Benefit Analysis, Female, Humans, Markov Chains, Middle Aged, Models, Theoretical, Tumor Virus Infections, Incidence, Risk Assessment, Papillomaviridae, Papillomavirus Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review